Mankind Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 145.00 Cr
as on 06-11-2024
- Paid Up Capital ₹ 138.51 Cr
as on 06-11-2024
- Company Age 4 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1676.58%
(FY 2023)
- Profit -334.58%
(FY 2023)
- Ebitda -299.62%
(FY 2023)
- Net Worth 141.05%
(FY 2023)
- Total Assets 56.46%
(FY 2023)
About Mankind Life Sciences
The Corporate was formerly known as Saburi Digital Technologies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 145.00 Cr and a paid-up capital of Rs 138.51 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mankind Life Sciences Private Limited India are Sandhya Gharana as Company Secretary, Sanjay Koul as Ceo, and Rahul Dua as Cfo. Akhlas Ahmed, Anju Jha, Abhay Srivastava, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24100DL2020PTC369904
- Company No.
369904
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Sep 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Mankind Life Sciences?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sandhya Gharana | Company Secretary | 01-Mar-2022 | Current |
Sanjay Koul  | CEO | 01-Oct-2022 | Current |
| Rahul Dua | CFO | 01-Oct-2022 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Abhay Srivastava | Director | 17-Sep-2021 | Current |
| Akhlas Ahmed | Director | 17-Sep-2021 | Current |
| Anju Jha | Additional Director | Current | |
| Anil Tyagi | Director | 17-Sep-2021 | Current |
| Naga Sundara | Whole-Time Director | 10-May-2023 | Current |
Financial Performance and Corporate Structure Insights of Mankind Life Sciences.
Mankind Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1676.58% increase. The company also saw a substantial fall in profitability, with a 334.58% decrease in profit. The company's net worth Soared by an impressive increase of 141.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mankind Life Sciences?
In 2023, Mankind Life Sciences had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sirmour Remedies Private LimitedActive 35 years 2 monthsAkhlas Ahmed and Abhay Srivastava are mutual person
Packtime Innovations Private LimitedActive 9 years 6 monthsAkhlas Ahmed and Anju Jha are mutual person
Relax Pharmaceuticals Private LimitedActive 27 years 4 monthsAkhlas Ahmed, Anju Jha and 1 more are mutual person
Copmed Pharmaceuticals Private LimitedActive 36 years 3 monthsAkhlas Ahmed, Anju Jha and 1 more are mutual person
Mediforce Healthcare Private LimitedActive 23 years 10 monthsAkhlas Ahmed and Abhay Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mankind Life Sciences?
Mankind Life Sciences has a workforce of 115 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mankind Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mankind Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
